PMCB Stock Price Prediction

PharmaCyte Biotech Inc

Add to Watchlist

Advanced Chart

0.830

-0.02(-2.353%)1D

Overview
Forecast
Valuation
Earnings

1-Day-Price-Prediction

+1.28%

1-Week Prediction

+2.88%

1-Month Prediction

+5.23%

2026 Prediction

+15.28%

2030 Prediction

+77.85%

Based on our advanced algorithm, we predict that PMCB stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $0.86, while the 1-week outlook suggests a value of $0.87. For the 1-month forecast, we project a price of $0.89. Looking further ahead, our 2026 projection estimates a value of $0.98, with a long-term 2030 forecast reaching $1.51. Stay informed and make strategic decisions with our data-driven insights!

Unlock Free Stock Price Forecast

0.890

Should I Buy PharmaCyte Biotech Inc Stock?

Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. PMCB has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.

PMCB stock price ended at $0.83 on Friday, after losing -2.35%

The PharmaCyte Biotech Inc stock price decreased by -2.35% on the last trading day (08 Aug 2025), dropping from 0.85 to 0.83. Throughout the last trading session, the stock experienced a fluctuation of 6.02% , ranging from a day low of $0.83 to a day high of 0.88. The price has declined in 5 of the last 10 days, resulting in a total change of -13.09% during this period. On the last day, trading volume increase by -20.56K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 21.38K shares were traded, amounting to approximately 18.50K.

PMCB Technical Signals

PMCB(PharmaCyte Biotech Inc Corp) has 6 buy signals and 4 sell signals now. The current trend is downtrend starting from 2025-08-06. The total price change during this trend is -2.35%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of PMCB over the last 5 trading days is 38.68K. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.

Get winning stock picks in minutes

PMCB Moving Average Analysis

PharmaCyte Biotech Inc's overall moving average trend leans more bearish as of Saturday, August 9, 2025, with 4 negative signals and 0 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $1.09, and $1.19. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $0.78, and $0.69. A break-down below any of these levels will issue sell signals.

PMCB Short Selling Analysis

The short sale ratio of PharmaCyte Biotech Inc(PMCB) as of 07 Aug 2025 is 26.79%, rising from last trading day. With increasing price from 0.85 to 0.85.

Technical Signal

Technical Signals Summary

Buy

Sell

Buy

Moving Average

Swing

Negative

Stock Price Below SMA_5

Short Term

Negative

SMA_5 Below SMA_20

Mid Term

Negative

SMA_20 Below SMA_60

Long Term

Negative

SMA_60 Below SMA_200

Short Selling

Close Price

Short Sale Ratio

Short Sale Volume

6 Bullish Signals

When Value satisfies Signal, Indicator signals Bullish

Indicators

Signal

Value

Meaning

Relative Strength Index (14 days)

RSI_14 < 30

26.22

Bullish

Stochastic Oscillator %K (14, 3, 3)

STOCHk_14_3_3 < 20

17.077

Bullish

Commodity Channel Index (20 days, 0.015 constant)

CCI_20_0.015 < -100

-214.551

Bullish

Stochastic RSI %K (14, 14, 3, 3)

STOCHRSIk_14_14_3_3 < 20

-0

Bullish

Williams %R (14 days)

WILLR_14 < -80

-88

Bullish

Ultimate Oscillator (7, 14, 28)

UO_7_14_28 < 30

26.297

Bullish

4 Bearish Signals

When Value satisfies Signal, Indicator signals Bearish

Indicators

Signal

Value

Meaning

Awesome Oscillator (5, 34)

AO_5_34 < 0

-0.106

Bearish

Momentum (10 days)

MOM_10 < 0

-0.125

Bearish

Moving Average Convergence Divergence (12, 26, 9)

MACD_12_26_9 < 0

-0.0468

Bearish

Closing price

close < fibonacci_S1

0.83

Bearish

PMCB Stock Forecast

2026

2027

2028

2029

2030

2031

2032

2033

2034

2035

Month	Min. Price	Avg. Price	Max. Price	Potential ROI

Jan 2026	$0.92	$0.94	$1.01	-8.73%
Feb 2026	$0.77	$0.94	$0.96	-9.13%
Mar 2026	$1.12	$1.13	$1.13	+9.77%
Apr 2026	$0.83	$0.94	$1.10	-8.91%
May 2026	$0.96	$1.03	$1.11	+0.31%
Jun 2026	$0.83	$0.98	$1.09	-4.89%
Jul 2026	$1.16	$1.21	$1.28	+17.01%
Aug 2026	$0.85	$0.98	$1.15	-4.86%
Sep 2026	$0.86	$0.92	$1.01	-10.75%
Oct 2026	$0.94	$1.12	$1.19	+8.50%
Nov 2026	$1.07	$1.07	$1.11	+4.07%
Dec 2026	$0.86	$0.95	$0.97	-8.22%

Unlock Free Stock Price Forecast

In 2026, PharmaCyte Biotech Inc (PMCB) is anticipated to change hands in a trading channel between $0.77 and $1.28.

PharmaCyte Biotech Inc Stock Forecast 2026

Jan 2026: PMCB Stock Forecast

Potential ROI: -8.73%

In Jan 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $0.94. The price is predicted to fluctuate between a low of $0.92 and a high of $1.01.

Feb 2026: PMCB Stock Forecast

Potential ROI: -9.13%

In Feb 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $0.94. The price is predicted to fluctuate between a low of $0.77 and a high of $0.96.

Mar 2026: PMCB Stock Forecast

Potential ROI: 9.77%

In Mar 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $1.13. The price is predicted to fluctuate between a low of $1.12 and a high of $1.13.

Apr 2026: PMCB Stock Forecast

Potential ROI: -8.91%

In Apr 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $0.94. The price is predicted to fluctuate between a low of $0.83 and a high of $1.10.

May 2026: PMCB Stock Forecast

Potential ROI: 0.31%

In May 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $1.03. The price is predicted to fluctuate between a low of $0.96 and a high of $1.11.

Jun 2026: PMCB Stock Forecast

Potential ROI: -4.89%

In Jun 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $0.98. The price is predicted to fluctuate between a low of $0.83 and a high of $1.09.

Jul 2026: PMCB Stock Forecast

Potential ROI: 17.01%

In Jul 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $1.21. The price is predicted to fluctuate between a low of $1.16 and a high of $1.28.

Aug 2026: PMCB Stock Forecast

Potential ROI: -4.86%

In Aug 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $0.98. The price is predicted to fluctuate between a low of $0.85 and a high of $1.15.

Sep 2026: PMCB Stock Forecast

Potential ROI: -10.75%

In Sep 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $0.92. The price is predicted to fluctuate between a low of $0.86 and a high of $1.01.

Oct 2026: PMCB Stock Forecast

Potential ROI: 8.50%

In Oct 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $1.12. The price is predicted to fluctuate between a low of $0.94 and a high of $1.19.

Nov 2026: PMCB Stock Forecast

Potential ROI: 4.07%

In Nov 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $1.07. The price is predicted to fluctuate between a low of $1.07 and a high of $1.11.

Dec 2026: PMCB Stock Forecast

Potential ROI: -8.22%

In Dec 2026, PharmaCyte Biotech Inc's value is forecasted to reach an average price of $0.95. The price is predicted to fluctuate between a low of $0.86 and a high of $0.97.

Get winning stock picks in minutes

PMCB Price Prediction & Forecast by Similar Chart Analysis

Based on historical patterns and backtesting of stocks with similar movements to PharmaCyte Biotech Inc(PMCB), our algorithm predicts PMCB's 1-month price at $0.89, with an -11.38%downwardshift. Using a similarity score up to 94.81%and other factors, This forecast updates weekly, adjusting for significant deviations.

Similar Chart

The price prediction chart for PharmaCyte Biotech Inc (PMCB.O) stock, as of Sunday, August 3, 2025 , forecasts a -11.38% change over the next month, based on its high correlation with NSC.N stock patterns. The similarity between their price movements over the analyzed periods is 94.81%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

PMCB

Future prediction

Up: -11.38%

Full Access. No Commitment.

7 Days Free!

AI Stock Picker

AI Swing Trade Signal

AI Earning Prediction

AI Screener

AI Financial Agent Help You Do Research

GET STARTED!

Already have an account? Sign In Here

NSC

Down: -11.38%Similarity: 94.81%

Name

Similarity

Up/Down

NSC.N

94.81%

-11.38%

BATL.A

94.18%

+115.41%

ALOT.O

93.96%

+15.39%

CGAU.N

93.64%

+11.34%

CLX.N

93.59%

+10.94%

BNGO.O

93.56%

-18.79%

FURY.A

93.51%

-5.23%

LYB.N

93.49%

-1.31%

MAS.N

93.39%

+9.77%

AJG.N

93.28%

+4.50%

PMCB Seasonality Analysis

Based on PMCB's historical stock price data across all years, the probability of a positive return in August is9.09%, suggesting it maynotbe an ideal month to invest in PMCB. In contrast,Januaryoffers the highest probability of positive returns at66.67%, making it a potentially strong month for investment.

However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.

Monthly Seasonality

The radar chart shows that buying PharmaCyte Biotech Inc (PMCB.O) stock in January has the highest probability of a positive return (66.67%), while August has the lowest probability (9.09%).

Performance Seasonality

The chart shows PharmaCyte Biotech Inc. (PMCB)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.